Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Equity Ratio (2019 - 2025)

Historic Equity Ratio for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to 0.02.

  • Biodesix's Equity Ratio fell 10715.85% to 0.02 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02, marking a year-over-year decrease of 10715.85%. This contributed to the annual value of 0.21 for FY2024, which is 36448.87% up from last year.
  • Per Biodesix's latest filing, its Equity Ratio stood at 0.02 for Q3 2025, which was down 10715.85% from 0.01 recorded in Q2 2025.
  • In the past 5 years, Biodesix's Equity Ratio registered a high of 0.32 during Q1 2021, and its lowest value of 0.09 during Q2 2023.
  • For the 5-year period, Biodesix's Equity Ratio averaged around 0.12, with its median value being 0.13 (2022).
  • Over the last 5 years, Biodesix's Equity Ratio had its largest YoY gain of 172728.45% in 2024, and its largest YoY loss of 21203.7% in 2024.
  • Over the past 5 years, Biodesix's Equity Ratio (Quarter) stood at 0.26 in 2021, then fell by 14.44% to 0.22 in 2022, then tumbled by 79.16% to 0.05 in 2023, then skyrocketed by 364.49% to 0.21 in 2024, then plummeted by 109.04% to 0.02 in 2025.
  • Its last three reported values are 0.02 in Q3 2025, 0.01 for Q2 2025, and 0.13 during Q1 2025.